Outset Medical (OM) Stock Price

Outset Medical Price

NASDAQ·CLOSED
4.15
​
Market closed

Revenue has compounded at 79.3% per year over the past 7 years to 119.48 M USD. Outset Medical's net margin stands at -68.3%, up from -128.6% several years earlier. Analysts set a median price target of 8.00 USD, implying 92.8% above the current price. Of 11 analysts, 9 rate the stock a buy — an overall Buy consensus.

Outset Medical stock price

Access this data via the Eulerpool API

Outset Medical business model & stock analysis

Outset Medical, Inc. is a medical technology company, which provides dialysis solutions to patients and healthcare providers. The company is headquartered in San Jose, California and currently employs 313 full-time employees. The company went IPO on 2020-09-15. The firm offers Tablo, a dialysis machine. Tablo offers acute and chronic dialysis. Tablo produces dialysate that’s customized to the patient’s prescription. Its touchscreen guidance and animated instructions enables to train new users. Tablo has integrated water purification and produces dialysis on demand. The other features of Tablo include integrated blood pressure cuff and automated saline bolus and tracking. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels and allows providers to a single platform from the hospital to the home. The three subtypes of hemodialysis that are used in the hospital are Intermittent Hemodialysis (IHD), Slow Low Efficiency Dialysis (SLED) and CRRT. IHD is used at the bedside or an inpatient dialysis unit outside of the ICU, while SLED and CRRT are used in the ICU.

Frequently asked questions about Outset Medical

Analysts currently set an average price target of 14.00 USD for the Outset Medical stock (median: 8.00 USD), implying +237.3 % versus the latest price. The consensus is based on 11 analyst ratings.

11 analysts currently rate the Outset Medical stock: 9 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Outset Medical to generate revenue of 125.97 M USD and earnings per share of -3.14 USD.

Converted at the current exchange rate, the Outset Medical share trades at 3.70 EUR (4.15 USD).

The Outset Medical share (OM) is listed on 1 stock exchanges, including: NASDAQ (OM).

The expected revenue of Outset Medical is 125.97 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Outset Medical is -56.02 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Outset Medical is currently -1.32. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Outset Medical stock.

The price-to-sales ratio (P/S) of Outset Medical is currently 0.59. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Outset Medical stock.

The Eulerpool Quality Score for Outset Medical is 2/10.

The ISIN of Outset Medical is US6901452069. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Outset Medical is A2QB2U. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Outset Medical is OM. The ticker symbol is used to trade Outset Medical shares on the stock exchange.

Fair ValueTerminal
4.03 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
385,406.45 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Sep 15, 2020
ISIN
US6901452069
Cusip
690145107
Sedol
BMGWSL0
Market capitalization
75.32 M USDMicro Cap
52-Week Range
PEG
0.03
P/E ratio
P/Ee 2026
-1.32
P/Ee 2027
-1.78
P/Ee 2028
-2.20
P/Ee 2029
-3.23
P/Ee 2030
-9.26
P/S
P/Se
0.59
EV/EBIT
—
P/B Ratio
0.59
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-35.78 %
Last updated Oct 10, 2026, 3:37 AM